Whole-body intelligence company brings in liver

The Longevity Show looks at priorities for healt

Raghav Sehgal and Albert Higgins-Chen on on why

New data suggest some younger adults with predia

Superpower announced a strategic partnership with

Well Health has partnered with AliveCor to offer

Designs for Health has launched NeuroCalm Peptide

Annovis secured U.S. Patent No.

Stealth BioTherapeutics CSO says bioenergetic dy

Baseline Nexus combines four established diagnos

Rhythm Pharmaceuticals’ IMCIVREE becomes the f

Annovis published a historical review of Buntanet

Humanaut will open a Dallas clinic at Preston Cen

Agentis Longevity and Ultrahuman announced a stra

I-Lumen Scientific announced on 31 March 2026 tha

After pulling in $1 billion across two private r

New US licensing deal brings chronic kidney dise

Allocetra moves into Phase 2b as Enlivex targets

Anavex Life Sciences withdrew its application for

Insilico Medicine announced a drug discovery coll

Allergan Aesthetics, an AbbVie company, presented

Aubrey De Grey breaks down longevity escape velo

Longevity biotech investment in 2026 is no longe

Researchers use AI to redesign antibody fragment

At AMWC Monaco, Allergan Aesthetics says the fut

New research shows that type 2 diabetes and wors

Alterity Therapeutics received positive feedback

With just weeks to go, the longevity industry’

With just weeks to go, the UK’s defining event

New Longevity Show blog explores how clinics are

New partnership brings early cognitive screening

Coordinated demonstrations across 14 cities set

$2.

Allergan Aesthetics, an AbbVie company, positione

Insilico Medicine and Tenacia Biotechnology are e

BCC Research has published a Pulse research title

Research projects the global cell therapy manufac

Phase 1 data suggest senotherapeutic activity in

Novo Nordisk’s higher-dose semaglutide arrives

Human Longevity and LEV Foundation will study ce

Cellbricks Therapeutics has raised €10 million

Alina M Hernandez and Nigel Franklyn on why long

Maze Therapeutics announced positive topline Phas

Human Longevity, Inc.

Rubedo Life Sciences reported preliminary Phase 1

Fresh funding backs a high-stakes attempt to do

SEMCAP is betting that longevity’s next growth

Immortal Dragons-backed Unlimited Bio registers

New data link popular weight-loss drugs to highe

Deal worth up to $150m comes as supplementation